Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraumbilical vs Intravenous Oxytocin for Third Stage of Labor
NCT07053930Completed
- Sponsor
- RESnTEC (Research and Technology) Ltd
- Start
- Oct 2024
- Primary completion
- Mar 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by RESnTEC (Research and Technology) Ltd. Primary endpoint: Duration of the third stage labour at 30 minutes. Started Oct 2024; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07053930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07053930.